Table 3 Entities in the HFPNe model of Figure 6

LIN-3(AC)

m ₁

LET-23

m ₂

LIN-3/LET-23 complex

m ₃

LIN-3/LET-23 dimer

m ₄

LIN-3/LET-23 dimer{p}

m ₅

SEM-5

m ₆

SEM-5{active}

m ₇

LET-60

m ₈

LET-60{active}

m ₉

MPK-1

m ₁₀

MPK-1{active}(C)

m ₁₁

MPK-1{active}(N)

m ₁₂

LIN-1/LIN-31 complex

m ₁₃

LIN-31{active}

m ₁₄

LIN-1{active}

m ₁₅

Vulval gene mRNA

m ₁₆

LS mRNA

m ₁₇

1° cell fate

m ₁₈

LS molecules(C)

m ₁₉

LIN-12/Notch receptor

m ₂₀

LIN-12R/LS complex

m ₂₁

Cleaved fraction of LIN-12R/LS (extracellular domain)

m ₂₂

Intracellular domain of LIN-12/LS complex (C)

m ₂₃

Intracellular domain of LIN-12/LS complex (N)

m ₂₄

LAG-1

m ₂₅

LST mRNA

m ₂₆

LST inhibitors

m ₂₇

LIN-3 emanating from hyp7

m ₂₈

LIN-15 in hyp7

m ₂₉

2° cell fate

m ₃₀

Final fate determined by Rule II

m ₃₁

Final fate determined by Rule I

m ₃₂